Patrice Allibert has been the CEO of OxyNov since March 2020. He holds a Ph.D. in molecular biology and microbiology and has more than 35 years of experience in four major biotechnology companies. He is the former CEO of GenePOC, a company that has since been acquired by Meridian BioSciences. Patrice began his career with bioMérieux in Lyon, France. He was Vice President R&D and Strategic Innovation for Molecular Infectious Diseases at Becton Dickinson in Québec City, where he developed and launched multiple diagnostic tests for hospital-acquired infections. He was also involved in the launch of multiple new vaccines in animal health with Merial in Athens, GA.

Jasmin Lavoie joined OxyNov in June 2020. Jasmin is a respiratory therapist whose credentials include Inh., RRT, an MBA, and a master’s degree in executive management. He is also a strategic medical and commercialization consultant through his private management company. He has more than 26 years of experience in medical industries with national and multinational companies and manufacturers. He also has strong clinical experience in hospital care, including adult, pediatric, and neonatal intensive care, as well as the emergency room, operating room, and respiratory ward. Over the years, he specialized in medical equipment commercialization and sales, clinical training, product launch, and marketing.

Jean L. Côté joined OxyNov in April 2020. Jean L. Côté, P. Eng., holds a bachelor's degree in mechanical engineering from Laval University, is a member of the Ordre des ingénieurs du Québec, and has more than 35 years of experience in the manufacturing industry. He held positions in variousCanadian and American corporations: Bose, Teknion, BD, GenePOC, and OxyNov. Over the course of his career in the office furniture industry and later in the medical device industry, he served in all related sectors: plant management, manufacturing engineering, product development, maintenance, continuous improvement, and health and safety. During these years, he developed broad expertise and now acts as a consultant for different companies in medtech.

Since September 2021, Marie-Josée has been the CFO of OxyNov, focusing on financing strategy, M&A, and cash management. She is also a strategic finance and governance consultant through her company Evolution CFO Consulting, serving clients mainly in life sciences and manufacturing. Previously, she was CFO at APN and GenePOC and Finance Director at Creaform and Anapharm. She holds a Bachelor of Science in Accounting and a Bachelor of Administration – Accounting. She obtained her Chartered Accountant designation (CPA-CA) in 1998 and began her career at KPMG. Marie-Josée also completed SME governance training with Desjardins Capital's Offensive F program.

Philippe Martineau is a CPA with 14 years of experience, as well as a bachelor’s degree in biochemistry. He has workedas a CPA in many industries, including manufacturing, aviation, entertainment, and medtech for the last 4 years with OxyNov.